Avapro

— THERAPEUTIC CATEGORIES —
  • Diabetes
  • Hypertension

Avapro Generic Name & Formulations

General Description

Irbesartan 75mg, 150mg, 300mg; tabs.

Pharmacological Class

Angiotensin II receptor blocker (ARB).

How Supplied

Tabs 75mg—90; 150mg, 300mg—30

Manufacturer

Generic Availability

YES

Avapro Indications

Indications

Diabetic nephropathy in patients with type 2 diabetes and hypertension.

Avapro Dosage and Administration

Adult

300mg once daily.

Children

Not recommended.

Avapro Contraindications

Contraindications

Concomitant aliskiren in patients with diabetes.

Avapro Boxed Warnings

Boxed Warning

Fetal toxicity.

Avapro Warnings/Precautions

Warnings/Precautions

Fetal toxicity may develop; discontinue if pregnancy is detected. Correct salt/volume depletion before beginning therapy, or reduce initial dose. Renal impairment: monitor. Severe CHF. Renal artery stenosis. Elderly. Neonates. Pregnancy: avoid. Nursing mothers: not recommended.

Avapro Pharmacokinetics

See Literature

Avapro Interactions

Interactions

Hyperkalemia with K+ supplements, K+ sparing diuretics, K+-containing salt substitutes. May increase lithium levels; monitor. May be antagonized by, and renal toxicity potentiated by, NSAIDs, including selective COX-2 inhibitors (monitor renal function periodically in elderly and/or volume depleted). Dual inhibition of the renin-angiotensin system with ARBs, ACEIs, or aliskiren may increase risk of hypotension, hyperkalemia, renal function changes; monitor closely. Concomitant aliskiren in renal impairment (CrCl <60mL/min): not recommended.

Avapro Adverse Reactions

Adverse Reactions

Diarrhea, dyspepsia, fatigue, orthostatic hypotension; increased liver function tests, anemia, hyperkalemia, tinnitus.

Avapro Clinical Trials

See Literature

Avapro Note

Not Applicable

Avapro Patient Counseling

See Literature

Avapro Generic Name & Formulations

General Description

Irbesartan 75mg, 150mg, 300mg; tabs.

Pharmacological Class

Angiotensin II receptor blocker (ARB).

How Supplied

Tabs 75mg—90; 150mg, 300mg—30

Manufacturer

Generic Availability

YES

Avapro Indications

Indications

Hypertension.

Avapro Dosage and Administration

Adult

≥16yrs: 150mg once daily; may increase to 300mg once daily. Or, may add a low dose of diuretic. Salt/volume depletion: initially 75mg once daily.

Children

Not recommended.

Avapro Contraindications

Contraindications

Concomitant aliskiren in patients with diabetes.

Avapro Boxed Warnings

Boxed Warning

Fetal toxicity.

Avapro Warnings/Precautions

Warnings/Precautions

Fetal toxicity may develop; discontinue if pregnancy is detected. Correct salt/volume depletion before beginning therapy, or reduce initial dose. Renal impairment: monitor. Severe CHF. Renal artery stenosis. Elderly. Neonates. Pregnancy: avoid. Nursing mothers: not recommended.

Avapro Pharmacokinetics

See Literature

Avapro Interactions

Interactions

Hyperkalemia with K+ supplements, K+ sparing diuretics, K+-containing salt substitutes. May increase lithium levels; monitor. May be antagonized by, and renal toxicity potentiated by, NSAIDs, including selective COX-2 inhibitors (monitor renal function periodically in elderly and/or volume depleted). Dual inhibition of the renin-angiotensin system with ARBs, ACEIs, or aliskiren may increase risk of hypotension, hyperkalemia, renal function changes; monitor closely. Concomitant aliskiren in renal impairment (CrCl <60mL/min): not recommended.

Avapro Adverse Reactions

Adverse Reactions

Diarrhea, dyspepsia, fatigue, dizziness, hyperkalemia.

Avapro Clinical Trials

See Literature

Avapro Note

Not Applicable

Avapro Patient Counseling

See Literature

Images